Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial

Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial

Abstract Background Microvascular blood flow (MBF) impairment in patients with lower extremity arterial disease (LEAD) is associated with more severe major adverse limb events (MALE). The contribution of ticagrelor, a P2Y12 antagonist and an adenosine enhancer, on blood viscosity (BV) and BV-depende...

Full description

Bibliographic Details
Main Authors: Robert S. Rosenson, Qinzhong Chen, Sherwin D. Najera, Prakash Krishnan, Martin L. Lee, Daniel J. Cho
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Cardiovascular Diabetology
Subjects:
Lower extremity arterial disease
Microvascular disease
Blood viscosity
Type 2 diabetes
Ticagrelor
Online Access:http://link.springer.com/article/10.1186/s12933-019-0882-5

Internet

http://link.springer.com/article/10.1186/s12933-019-0882-5

Similar Items